pmc logo imageJournal ListSearchpmc logo image
Logo of pnasPNAS Home page.Reference to the article.PNAS Info for AuthorsPNAS SubscriptionsPNAS About
Proc Natl Acad Sci U S A. 1979 June; 76(6): 2881–2885.
PMCID: PMC383713
Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.
K H Gabbay, R M Bergenstal, J Wolff, M E Mako, and A H Rubenstein
Abstract
Familial hyperproinsulinemia is an autosomal dominant defect that is associated with strikingly elevated levels of serum proinsulin-like material. Our studies show that trypsin converts familial hyperproinsulinemia proinsulin to insulin more slowly than it converts a 131I-labeled porcine proinsulin marker. Molar yields of insulin indicated that the material may be an intermediate proinsulin. Studies with two human C-peptide antisera that differ in their relative immunoreactivity with human C-peptide and proinsulin showed that the two antisera reacted equally with familial hyperproinsulinemia proinsulin, suggesting that it is a partially cleaved proinsulin intermediate. Sulfitolysis of highly purified material to break the inter- and intra-chain disulfide bridges and subsequent adsorption on a specific B-chain antibody covalently bound to Sepharose beads showed that the C-peptide was still connected to the B-chain. These data indicate that familial hyperproinsulinemia proinsulin is normally cleaved at the C-peptide-A-chain linkage site. A structural abnormality appears to underlie familial hyperproinsulinemia proinsulin, which impairs its cleavage at the B-chain-C-peptide linkage site.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Gabbay, KH; DeLuca, K; Fisher, JN, Jr; Mako, ME; Rubenstein, AH. Familial hyperproinsulinemia. An autosomal dominant defect. N Engl J Med. 1976 Apr 22;294(17):911–915. [PubMed]
  • Kuzuya, H; Blix, PM; Horwitz, DL; Rubenstein, AH; Steiner, DF; Binder, C; Faber, OK. Heterogeneity of circulating C-peptide. J Clin Endocrinol Metab. 1977 May;44(5):952–962. [PubMed]
  • Freychet, P; Roth, J; Neville, DM., Jr Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun. 1971 Apr 16;43(2):400–408. [PubMed]
  • HUNTER, WM; GREENWOOD, FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. [PubMed]
  • Kemmler, W; Peterson, JD; Steiner, DF. Studies on the conversion of proinsulin to insulin. I. Conversion in vitro with trypsin and carboxypeptidase B. J Biol Chem. 1971 Nov 25;246(22):6786–6791. [PubMed]
  • Gutman, RA; Lazarus, NR; Recant, L. Electrophoretic characterization of circulating human proinsulin and insulin. Diabetologia. 1972 Apr;8(2):136–140. [PubMed]
  • Steiner, DF; Cho, S; Oyer, PE; Terris, S; Peterson, JD; Rubenstein, AH. Isolation and characterization of proinsulin C-peptide from bovine pancreas. J Biol Chem. 1971 Mar 10;246(5):1365–1374. [PubMed]
  • Chance, RE. Amino acid sequences of proinsulins and intermediates. Diabetes. 1972;21(2 Suppl):461–467. [PubMed]